Literature DB >> 9635677

Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products.

L C Archard1, M A Khan, B A Soteriou, H Zhang, H J Why, N M Robinson, P J Richardson.   

Abstract

This study was performed to detect and characterize the enterovirus present in myocardium of some patients with heart muscle disease by nucleotide sequencing of polymerase chain reaction (PCR) products after amplification with enterovirus group-specific primers. Enterovirus sequences have been detected previously in myocardium of patients with myocarditis or dilated cardiomyopathy and seem causal, although the particular virus serotypes involved have not been identified. In a prospective study of endomyocardial biopsy specimens from 35 consecutive patients with suspected heart muscle disease, enterovirus sequences from the 5' nontranslated region were amplified by reverse transcription-nested PCR using group-specific primers. This region contains both conserved and variable sequence motifs, characteristic of particular enterovirus serotypes. The nucleotide sequences of individual PCR products were determined by cycle sequencing and compared with all known sequences (GenBank/EMBOL), using the GCG software package. Endomyocardial biopsy specimens from 9 of 21 (42.9%) patients with a histologically confirmed diagnosis of dilated cardiomyopathy were positive for enterovirus by PCR, compared with only 1 of 14 (7.1%) patients with other myocardial pathological conditions (Fisher's exact probability=0.0275: odds ratio=9.75; 95% confidence interval=1.31-72.78). The nucleotide sequence of the PCR products differed, indicating no cross-contamination. However, computerized comparison showed that each had greatest homology with the 5' nontranslated region of Coxsackie B virus but contained up to 11% sequence variations compared with the prototype Coxsackie B3 strain Nancy. Parallel investigation of tissue from our mouse model of Coxsackievirus B3-induced myocarditis showed that nucleotide sequence changes are not introduced by reverse transcription or PCR. These data support the link between enteroviral infection and dilated heart muscle disease and suggest that Coxsackie B serotypes are the enteroviruses most frequently involved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635677     DOI: 10.1016/s0046-8177(98)80006-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

Review 1.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Absence of viral nucleic acids in early and late dilated cardiomyopathy.

Authors:  N G Mahon; B Zal; G Arno; P Risley; J Pinto-Basto; W J McKenna; M J Davies; C Baboonian
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Sex-Dependent Intestinal Replication of an Enteric Virus.

Authors:  Christopher M Robinson; Yao Wang; Julie K Pfeiffer
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

4.  High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China.

Authors:  Y Li; T Peng; Y Yang; C Niu; L C Archard; H Zhang
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 5.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

6.  Enterovirus related metabolic myopathy: a postviral fatigue syndrome.

Authors:  R J M Lane; B A Soteriou; H Zhang; L C Archard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

Review 7.  [State of diagnostics and therapy of inflammatory cardiomyopathie].

Authors:  H P Schultheiss; U Kühl
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

8.  Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes.

Authors:  Hongyi Zhang; Yanwen Li; Dougal R McClean; Peter J Richardson; Richard Florio; Mary Sheppard; Karen Morrison; Najma Latif; Michael J Dunn; Leonard C Archard
Journal:  Med Microbiol Immunol       Date:  2003-11-22       Impact factor: 3.402

9.  Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Daniel E Hassett; J Lindsay Whitton
Journal:  Med Microbiol Immunol       Date:  2003-08-19       Impact factor: 3.402

10.  5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.

Authors:  Nora M Chapman; Kyung-Soo Kim; Kristen M Drescher; Kuniyuki Oka; Steven Tracy
Journal:  Virology       Date:  2008-04-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.